NIH-funded research U01 cooperative agreement

Understanding how well vaccines work against respiratory viruses in real-world settings

Official title: RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real World

Funded at Washington University · NIH-10909767 · Data updated 2026-11-12

This study is looking at how well flu and COVID-19 vaccines work for people with respiratory infections, and it’s for anyone who wants to understand more about vaccine protection in real-life situations.

More Respiratory Tract Infections research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2027
Funding year2024
Award (this year)$1,900,000
NIH project number5U01IP001182-03
Project IDNIH-10909767 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include individuals experiencing acute respiratory illnesses who are seeking outpatient care.

Less likely to help

Patients who are not currently experiencing respiratory infections or those who have already been vaccinated may not benefit from this research.

What this research studies

This research investigates the effectiveness of vaccines against influenza and SARS-CoV-2 in patients experiencing respiratory infections. By employing a multidisciplinary approach, the study aims to recruit a diverse group of ambulatory patients using automated alerts and advanced data collection methods. The research team, composed of experts from various fields, will analyze samples and data to assess how well these vaccines protect against these viral infections in everyday situations. The findings will help inform public health strategies and improve vaccine deployment.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccine strategies that enhance protection against respiratory viruses for the general population.

How similar studies have gone: Previous research has successfully utilized similar multidisciplinary approaches to assess vaccine effectiveness, indicating a promising potential for this study.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: House, Stacey — Washington University
  • Study coordinator: House, Stacey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.